Literature DB >> 8944607

Oncogenic human papillomaviruses and ploidy in cervical lesions.

S Rihet1, M Lorenzato, C Clavel.   

Abstract

AIM: To compare ploidy measurements obtained on tissue sections of selected low and high grade squamous intraepithelial lesions containing oncogenic HPV (types 16, 18 or 33) detected by in situ hybridisation (ISH) or PCR.
METHODS: DNA ploidy was assessed by image cytometry after Feulgen staining of contiguous serial sections of eight lesions exhibiting atypical squamous cells or squamous atypia and 53 low and 63 high grade squamous intraepithelial lesions in which HPV had been detected by ISH or PCR.
RESULTS: Aneuploidy was strongly associated with the presence of oncogenic HPV, being detected in 50% of lesions with squamous atypia and 75.5% of the low and 95.2% of the high grade squamous intraepithelial lesions. The multiploid profile was highly associated with high grade lesions and with the pattern of HPV DNA integration.
CONCLUSIONS: The presence of aneuploidy is strongly suggestive of the presence of oncogenic HPV types. Combining the detection of HPV by ISH and PCR with DNA image cytometry may provide the pathologist and the physician with important prognostic information about low grade lesions, especially when these lesions have a multiploid DNA profile and contain oncogenic HPV.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8944607      PMCID: PMC500827          DOI: 10.1136/jcp.49.11.892

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  29 in total

1.  Immortalization of human cervical keratinocytes by human papillomavirus type 33.

Authors:  C Gilles; J Piette; S Rombouts; C Laurent; J M Foidart
Journal:  Int J Cancer       Date:  1993-03-12       Impact factor: 7.396

2.  [Quantification of DNA using image analysis on paraffin sections].

Authors:  M Lorenzato; A Lallemand; B Visseaux-Coletto; D Gaillard
Journal:  Ann Pathol       Date:  1994       Impact factor: 0.407

Review 3.  Cytometric DNA analysis in the management of cancer. Clinical and laboratory considerations.

Authors:  C J Herman
Journal:  Cancer       Date:  1992-03-15       Impact factor: 6.860

4.  Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance.

Authors:  J T Cox; A T Lorincz; M H Schiffman; M E Sherman; A Cullen; R J Kurman
Journal:  Am J Obstet Gynecol       Date:  1995-03       Impact factor: 8.661

5.  A new nonisotopic detection of human papillomavirus DNA using polymerase chain reaction.

Authors:  I Binninger; C Clavel; M Polette; M C Boutterin; C Chypre; B Alpha; P Birembaut
Journal:  Diagn Mol Pathol       Date:  1992-12

6.  Human papillomavirus type 16 in cervical smears as predictor of high-grade cervical intraepithelial neoplasia [corrected].

Authors:  J Cuzick; G Terry; L Ho; T Hollingworth; M Anderson
Journal:  Lancet       Date:  1992-04-18       Impact factor: 79.321

7.  DNA content measurement and in situ hybridization in condylomatous cervical lesions.

Authors:  C Clavel; L Zerat; I Binninger; M C Boutterin; M Polette; J Monsonego; P Birembaut
Journal:  Diagn Mol Pathol       Date:  1992-09

8.  The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months.

Authors:  A J Remmink; J M Walboomers; T J Helmerhorst; F J Voorhorst; L Rozendaal; E K Risse; C J Meijer; P Kenemans
Journal:  Int J Cancer       Date:  1995-05-04       Impact factor: 7.396

9.  Relation between human papillomavirus type 16 and potential for progression of minor-grade cervical disease.

Authors:  G P Downey; P J Bavin; A R Deery; J Crow; P D Griffiths; V C Emery; P G Walker
Journal:  Lancet       Date:  1994-08-13       Impact factor: 79.321

10.  Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

Authors:  F X Bosch; M M Manos; N Muñoz; M Sherman; A M Jansen; J Peto; M H Schiffman; V Moreno; R Kurman; K V Shah
Journal:  J Natl Cancer Inst       Date:  1995-06-07       Impact factor: 13.506

View more
  4 in total

Review 1.  Human papillomavirus oncoproteins: pathways to transformation.

Authors:  Cary A Moody; Laimonis A Laimins
Journal:  Nat Rev Cancer       Date:  2010-07-01       Impact factor: 60.716

Review 2.  Oncogenic activities of human papillomaviruses.

Authors:  Margaret E McLaughlin-Drubin; Karl Münger
Journal:  Virus Res       Date:  2009-06-18       Impact factor: 3.303

Review 3.  The human papillomavirus E7 oncoprotein.

Authors:  Margaret E McLaughlin-Drubin; Karl Münger
Journal:  Virology       Date:  2008-11-12       Impact factor: 3.616

Review 4.  Human papillomavirus and genome instability: from productive infection to cancer.

Authors:  Bruna Prati; Bruna Marangoni; Enrique Boccardo
Journal:  Clinics (Sao Paulo)       Date:  2018-09-06       Impact factor: 2.365

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.